Tenet Healthcare THC · NYSE
$266.66 -0.22% (-$0.60)
Summary
71 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 60% a year over the last 3 years.
- You pay 9.6 USD for 1 USD of yearly profit, little for its sector.
- It bought back its own shares for $1.44B in the last fiscal year, 6.7% of its market value.
- Out of every 100 USD of revenue, 14 USD is left as free cash.
What to watch
- For every 100 USD of shareholders' equity it carries 284 USD of debt.
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 9.6 USD for 1 USD of yearly profit. Over the last five years it was 10.5 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 3.9% a year over 5 years. Over the last 3 years it grew by 3.6% a year. For the next fiscal year analysts expect revenue to grow by 4.3%. Earnings per share grew by 60% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 73 USD
- Sales and administration 10 USD
- Taxes and other 6.5 USD
- Net profit 10 USD
Net profit, industry median (Medical - Care Facilities) 6.7 USD
Out of every 100 USD of revenue, 10 USD is left as net profit.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 4.4 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 26
- Hold 6
- Sell 0
Today's price within the analysts' price targets
The average target of $283.36 is 6.3% above today's price. 81% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Ambulatory Care 50%
- Hospital Operations 50%
By region
The company reports no revenue by region.
Ambulatory Care brings in 50% of revenue.
Segments in detail